Search Results - "Bai, Barbara"
-
1
Variation of use of targeted therapies and molecular diagnostic testing by practice type for non-small cell lung cancer and colorectal cancer
Published in Journal of clinical oncology (01-06-2022)“…6551 Background: Targeted therapies are important first-line treatments for many patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC)…”
Get full text
Journal Article -
2
-
3
Measuring disparities in quality of oncology care across oncology practices
Published in Journal of clinical oncology (20-05-2021)“…Abstract only 6533 Background: Equity is now recognized as an essential aspect of health care quality. Racial inequities in clinical performance diminish…”
Get full text
Journal Article -
4
Measuring Racial Inequities In The Quality Of Care Across Oncology Practices In The US
Published in Health affairs (Millwood, Va.) (01-04-2022)“…Racial inequities in clinical performance diminish overall health care system performance; however, quality assessments have rarely incorporated reliable…”
Get full text
Journal Article -
5
National Rates of Initiation and Intensification of Antidiabetic Therapy Among Patients With Commercial Insurance
Published in Diabetes care (01-08-2018)“…Prompt initiation and intensification of antidiabetic therapy can delay or prevent complications from diabetes. We sought to understand the rates of and…”
Get full text
Journal Article -
6
Abstract 35: Trends in Statin Use and Adherence and the Impact of the 2013 Cholesterol Guidelines
Published in Circulation Cardiovascular quality and outcomes (01-04-2018)“…Abstract only Background: In 2013, the ACC/AHA updated the cholesterol treatment guidelines. At the time, it was estimated that an additional 13 million…”
Get full text
Journal Article -
7
Association Between Clinical Practice Group Adherence to Quality Measures and Adverse Outcomes Among Adult Patients With Diabetes
Published in JAMA network open (02-08-2019)“…Clinical practice group performance on quality measures associated with chronic disease management has become central to reimbursement. Therefore, it is…”
Get full text
Journal Article